Active Ingredients (Ref. Standards)
Each tablet contains:
Aloes soco D6 — 0.001 mg (HPUS)
Alumen D3 — 0.001 mg (HPUS)
Bryonia D7 — 0.001 mg (HPUS)
Croton tig D7 — 0.0001 mg (HPUS)
Hydrastis can D5 — 0.001 mg (HPUS)
Mag mur D3 — 0.1 mg (HPUS)
Phenolphthalein D2 — 60 mg (EHPI)
Indications
Help support to relieve the symptoms of acute and habitual constipation. For detail please read the enclosed package (product information leaflet).
Indications
Help support to relieve the symptoms of acute and habitual constipation. For detail please read the enclosed package (product information leaflet).
Dosage
Adult: Two tablets at bedtime.
Teenager: Half of the same.
Precautions / Storage
Keep away from children and store at a cool and dry place
Precautions / Storage
Keep away from children and store at a cool and dry place
Potato Starch, Dicalcium Phosphate Anhydrous, Microcrystalline Cellulose, Lactose Monohydrate, Povidone K-30, Magnesium Stearate, Silicon Dioxide, Hypromellose, Polyethylene Glycol, Titanium Dioxide, FD&C Yellow No. 5, Carmoisine.
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Data code | QR Code | BM Homoeopathic Pharmaceuticals Homoeolax 30 tablets Help support to relieve the symptoms of acute and habitual constipation DRAP Mfg. Enl. # 0041, Prod. Enl. # 0041881043 | Homoeolax Tablet - Carton.jpg |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 85816-6031 | 85816-6031-1 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BM HOMOEOLAX | ALOE SOCO, BRYONIA ALBA, CROTON TIG, HYDRASTIS CAN, ALUMEN, MAG MUR, PHENOLPHTHALEIN | BM Private Limited | 5324c47d-d085-dca0-e063-6394a90a92f9 | 2026-05-31 | Warnings | 85816-6031-1 85816-6031 85816603101 5324c47d-d086-dca0-e063-6394a90a92f9 5324c47d-d085-dca0-e063-6394a90a92f9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.